9.00
0.00
(0.00%)
At close: January 9 at 8:00:22 AM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -0.04 | -0.04 |
| Low Estimate | 0 | 0 | -0.05 | -0.04 |
| High Estimate | 0 | 0 | -0.03 | -0.03 |
| Year Ago EPS | -- | -- | -0.04 | -0.04 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 2.65M | 6.2M |
| Low Estimate | -- | -- | 2.5M | 4.9M |
| High Estimate | -- | -- | 2.8M | 7.5M |
| Year Ago Sales | -- | -- | 1.2M | 2.65M |
| Sales Growth (year/est) | -- | -- | 120.28% | 133.96% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.04 | -0.04 |
| 7 Days Ago | 0 | 0 | -0.04 | -0.04 |
| 30 Days Ago | 0 | 0 | -0.04 | -0.04 |
| 60 Days Ago | 0 | 0 | -0.05 | -0.04 |
| 90 Days Ago | 0 | 0 | -0.05 | -0.04 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OBI.L | -- | -- | -1.24% | 12.23% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Related Tickers
SLNCF Silence Therapeutics plc
1.6350
0.00%
ROQ.L Roquefort Therapeutics plc
3.6500
-9.88%
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
GSTC GlobeStar Therapeutics Corporation
0.0004
-12.50%
OCC.AX Orthocell Limited
1.3800
-2.82%
SLN Silence Therapeutics plc
5.99
-5.52%
ITRM Iterum Therapeutics plc
1.6500
-8.33%
NNVC NanoViricides, Inc.
1.3500
-2.88%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
MESO Mesoblast Limited
17.18
0.00%